Stocks CHD Financial statements
Financial statementsCHURCH & DWIGHT CO INC /DE/ financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CHURCH & DWIGHT CO INC /DE/ files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,493 | 3,776 | 4,146 | 4,358 | 4,896 | 5,190 | 5,376 | 5,868 | 6,107 | 6,203 |
| Cost of revenue | 1,903 | 2,047 | 2,305 | 2,374 | 2,682 | 2,927 | 3,126 | 3,279 | 3,317 | 3,428 |
| Gross profit | 1,591 | 1,730 | 1,841 | 1,984 | 2,214 | 2,264 | 2,250 | 2,589 | 2,790 | 2,775 |
| Research and development | 63.2 | 70.8 | 89.7 | 93.6 | 103 | 105 | 110 | 122 | 140 | 146 |
| Selling, general and administrative | 439 | 543 | 566 | 629 | 593 | 607 | 706 | 890 | 928 | 988 |
| Selling and marketing | 427 | 454 | 483 | 515 | 591 | 578 | 535 | 641 | 698 | 709 |
| Operating income | 724 | 733 | 792 | 840 | 1,030 | 1,079 | 598 | 1,057 | 807 | 1,078 |
| Interest expense | 27.7 | 52.6 | 79.4 | 73.6 | 61 | 54.5 | 89.6 | 111 | 95 | 95.2 |
| Other non-operating income | -1.5 | -0.3 | -3.9 | -1.1 | -2.1 | -2.3 | -1 | -0.8 | 8.8 | -56.9 |
| Pre-tax income | 706 | 693 | 720 | 774 | 974 | 1,032 | 523 | 967 | 756 | 957 |
| Income tax | 247 | -50.7 | 151 | 158 | 188 | 204 | 109 | 212 | 171 | 220 |
| Net income | 459 | 743 | 569 | 616 | 786 | 828 | 414 | 756 | 585 | 737 |
| EBITDA | 832 | 858 | 933 | 1,017 | 1,219 | 1,298 | 817 | 1,283 | 1,046 | 1,325 |
| EPS, basic | 1.78 | 2.97 | 2.32 | 2.50 | 3.18 | 3.38 | 1.70 | 3.09 | 2.39 | 3.04 |
| EPS, diluted | 1.75 | 2.90 | 2.27 | 2.44 | 3.12 | 3.32 | 1.68 | 3.05 | 2.37 | 3.02 |
| Shares, basic (weighted) | 258 | 251 | 246 | 246 | 247 | 245 | 243 | 245 | 244 | 243 |
| Shares, diluted (weighted) | 262 | 256 | 251 | 252 | 252 | 250 | 246 | 248 | 247 | 244 |
| Dividend per share | 0.71 | 0.76 | 0.87 | 0.91 | 0.96 | 1.01 | 1.05 | 1.09 | 1.13 | 1.18 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 188 | 279 | 317 | 156 | 183 | 241 | 270 | 345 | 964 | 409 |
| Receivables | 287 | 346 | 345 | 356 | 399 | 406 | 422 | 527 | 601 | 593 |
| Inventory | 258 | 331 | 383 | 417 | 495 | 535 | 647 | 613 | 613 | 535 |
| Other current assets | 23.8 | 44.7 | 33.4 | 26.9 | 35.1 | 51.9 | 57 | 45 | 62.4 | 59.8 |
| Total current assets | 757 | 1,000 | 1,078 | 956 | 1,112 | 1,233 | 1,396 | 1,530 | 2,241 | 1,597 |
| Property, plant and equipment | 589 | 608 | 598 | 598 | 613 | 653 | 761 | 928 | 932 | 823 |
| Lease right-of-use assets | 55 | 151 | 182 | 159 | 163 | 186 | 182 | 166 | ||
| Goodwill | 1,444 | 1,959 | 1,993 | 2,080 | 2,230 | 2,275 | 2,427 | 2,432 | 2,433 | 2,628 |
| Intangible assets | 1,432 | 2,321 | 2,274 | 2,750 | 3,110 | 3,494 | 3,432 | 3,302 | 2,889 | 3,512 |
| Other non-current assets | 124 | 118 | 117 | 117 | 340 | 333 | 318 | 366 | 378 | 343 |
| Total assets | 4,354 | 6,015 | 6,069 | 6,657 | 7,415 | 7,997 | 8,346 | 8,569 | 8,883 | 8,912 |
| Accounts payable | 332 | 399 | 430 | 473 | 588 | 664 | 667 | 631 | 705 | 732 |
| Accrued liabilities | 73.2 | 61.8 | 84.2 | 96.5 | 124 | 87.7 | 66.8 | 152 | 151 | 146 |
| Short-term debt | 427 | 0 | 597 | 0 | 0 | 699 | 0 | 200 | 0 | 0 |
| Total current liabilities | 1,002 | 935 | 1,326 | 1,092 | 1,389 | 2,075 | 1,184 | 1,422 | 1,316 | 1,498 |
| Long-term debt | 693 | 2,103 | 1,509 | 1,810 | 1,813 | 2,202 | 2,600 | 2,202 | 2,205 | 2,205 |
| Lease liabilities | 144 | 168 | 147 | 152 | 175 | 169 | 153 | |||
| Other non-current liabilities | 169 | 197 | 181 | 181 | 368 | 298 | 273 | 314 | 333 | 321 |
| Total liabilities | 2,376 | 3,797 | 3,615 | 3,990 | 4,394 | 4,763 | 4,856 | 4,714 | 4,522 | 4,910 |
| Total debt | 693 | 2,103 | 2,105 | 1,810 | 1,813 | 2,310 | 2,600 | 2,402 | 2,205 | 2,205 |
| Paid-in capital | 251 | 265 | 281 | 296 | 274 | 310 | 366 | 455 | 563 | 625 |
| Retained earnings | 2,926 | 3,479 | 3,833 | 3,833 | 4,786 | 5,366 | 5,525 | 6,012 | 6,320 | 6,768 |
| Treasury stock | -1,429 | -1,782 | -1,899 | -2,091 | -2,255 | -2,668 | -2,665 | -2,878 | -2,785 | -3,665 |
| Other comprehensive income | -63.8 | -36.4 | -53.6 | -66.7 | -77.6 | -68.2 | -29.3 | -27.2 | -30.9 | -19.9 |
| Shareholders' equity | 1,978 | 2,218 | 2,454 | 2,668 | 3,020 | 3,233 | 3,490 | 3,855 | 4,361 | 4,002 |
| Total equity | 1,978 | 2,218 | 2,454 | 2,668 | 3,020 | 3,233 | 3,490 | 3,855 | 4,361 | 4,002 |
| Total liabilities and equity | 4,354 | 6,015 | 6,069 | 6,657 | 7,415 | 7,997 | 8,346 | 8,569 | 8,883 | 8,912 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 459 | 743 | 569 | 616 | 786 | 828 | 414 | 756 | 585 | 737 |
| Depreciation and amortization | 108 | 125 | 141 | 176 | 190 | 219 | 219 | 225 | 239 | 247 |
| Stock-based compensation | 16 | 18.1 | 23.3 | 20.8 | 21.5 | 23.7 | 32.3 | 63.6 | 59.2 | 58 |
| Deferred income tax | 24.9 | -238 | 11.1 | 5.6 | 25.7 | 20.3 | -118 | -13.8 | -82 | 36 |
| Change in receivables | -12.7 | -9.7 | -3.4 | -9.2 | -13.4 | 2.4 | -5.3 | -97.4 | -81.5 | 39.4 |
| Change in inventory | 19.2 | -25.2 | -55.1 | -33.8 | -61.9 | -29.1 | -92.8 | 38.5 | 2 | 56.1 |
| Change in payables | 50.5 | 30.3 | 54.9 | 72.8 | 168 | 47.5 | 6.9 | -58.1 | 98.6 | 2.4 |
| Cash from operations | 655 | 682 | 764 | 865 | 990 | 994 | 885 | 1,031 | 1,156 | 1,215 |
| Capital expenditures | -49.8 | -45 | -60.4 | -73.7 | -98.9 | -119 | -179 | -224 | -180 | -122 |
| Acquisitions | -305 | -1,260 | -49.8 | -475 | -513 | -556 | -547 | 0 | -19.9 | -656 |
| Cash from investing | -355 | -1,303 | -112 | -554 | -608 | -682 | -729 | -234 | -183 | -617 |
| Debt issued | 0 | 1,621 | 0 | 300 | 0 | 799 | 999 | 0 | 0 | |
| Debt repaid | 0 | -200 | 0 | -600 | 0 | -300 | -700 | -200 | -205 | 0 |
| Stock issued | 50.5 | 42.1 | 76.6 | 52.8 | 93 | 98.7 | 26.2 | 112 | 143 | 35.6 |
| Share buybacks | -400 | -400 | -200 | -250 | -300 | -500 | 0 | -300 | 0 | -900 |
| Dividends paid | -183 | -190 | -213 | -224 | -237 | -248 | -255 | -267 | -277 | -287 |
| Cash from financing | -440 | 699 | -609 | -473 | -360 | -252 | -121 | -726 | -343 | -1,162 |
| Exchange rate effect | -3.3 | 14.1 | -4.7 | 0.9 | 5.3 | -2.2 | -6 | 3.5 | -9.9 | 8.8 |
| Net change in cash | -142 | 91.1 | 37.8 | -161 | 27.4 | 57.5 | 29.7 | 74.2 | 620 | -555 |
| Free cash flow | 606 | 637 | 703 | 791 | 891 | 875 | 706 | 807 | 976 | 1,093 |
| Interest paid | 25.6 | 33.3 | 74.9 | 70.6 | 58.8 | 51.8 | 86 | 112 | 94.4 | 94.6 |
| Income taxes paid | 188 | 198 | 117 | 135 | 162 | 203 | 213 | 228 | 260 | 188 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 45.6% | Gross profit / revenue. |
| Operating margin | 17.5% | Operating income / revenue. |
| EBITDA margin | 20.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 15.3% | Pre-tax income / revenue. |
| Net margin | 12.0% | Net income / revenue. |
| Effective tax rate | 21.8% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 17.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 8.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | 13.5% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 2.3% | Research and development expense / revenue. |
| SG&A / revenue | 16.6% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 1.1% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.3% | Capital expenditures / revenue. |
| D&A / revenue | 3.4% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 1.6% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 4.9% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 4.8% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -0.5% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 7.2% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 4.6% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 33.5% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 21.7% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 0.9% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 26.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 17.5% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 1.7% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 25.9% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 21.2% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | -1.3% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 27.4% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 21.6% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | -0.6% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 5.1% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 11.1% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 4.2% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 11.9% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 15.7% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 4.2% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Dividend per share growth, 1y | 4.4% | Dividend per share vs the same period a year earlier. Only from a positive base. |
| Dividend per share CAGR, 3y | 4.0% | Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Dividend per share CAGR, 5y | 4.2% | Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -8.2% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 4.7% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 5.8% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 0.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 2.2% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 3.7% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -1.1% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -0.3% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -0.6% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.15x | Current assets / current liabilities. |
| Quick ratio | 0.64x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.19x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.51x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 24.2% | Total debt / total assets. |
| Liabilities / assets | 52.3% | Total liabilities / total assets. |
| Net debt | $1.95B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 1.50x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 11.3x | Operating income / interest expense. |
| Working capital | $194.5M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 70.2% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$2.05B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.68x | Revenue / average total assets. |
| Fixed asset turnover | 7.54x | Revenue / average property, plant and equipment. |
| Inventory turnover | 5.62x | Cost of revenue / average inventory. |
| Days inventory | 65 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 10.4x | Revenue / average receivables. |
| Days sales outstanding | 35 days | 365 x average receivables / revenue. |
| Days payables | 84 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 16 days | Days inventory + days sales outstanding - days payables. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $3.13 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $26.15 | Revenue / diluted weighted shares. |
| Book value per share | $18.25 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$8.59 | Tangible book value / shares outstanding. |
| Cash per share | $1.07 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 38.7% | Dividends paid / net income, when net income is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $22.86B | Share price x shares outstanding. |
| Enterprise value | $24.81B | Market cap + total debt - cash - short-term investments. |
| P/E | 30.7x | Market cap / net income. Only when net income is positive. |
| P/S | 3.67x | Market cap / revenue. |
| P/B | 5.26x | Market cap / shareholders' equity. Only when equity is positive. |
| EV/Sales | 3.98x | Enterprise value / revenue. |
| EV/EBIT | 22.8x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 19.0x | Enterprise value / EBITDA, when both are positive. |
| Earnings yield | 3.3% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 1.3% | Dividends paid over the period / market cap. |
| Shareholder yield | 1.3% | (Dividends paid + share buybacks) / market cap. |
| PEG | 1.42x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was CHURCH & DWIGHT CO INC /DE/'s revenue in fiscal 2025?
CHURCH & DWIGHT CO INC /DE/ reported revenue of $6.20B for fiscal 2025, 1.6% higher than the year before.
Was CHURCH & DWIGHT CO INC /DE/ profitable in fiscal 2025?
Yes. Net income was $736.8M, a net margin of 11.9%.
How much free cash flow did CHURCH & DWIGHT CO INC /DE/ generate in fiscal 2025?
Cash from operations of $1.22B minus capital expenditures of $122.4M left free cash flow of $1.09B.